Michael O’Donnell, M.D., FACS at Bladder Cancer Advocacy Network – BCAN


About Us Financials Mission & Background What We Do Accomplishments Board of Directors Staff Scientific Advisory Board Press Quick Links Frequently Asked Questions BCG Shortage Information Join Our Mailing List Clinical Trials Clinical Trials Matching Service Volunteer Donate Patient Tips Online Store Walk for Bladder Cancer What's Up, Doc? The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012. We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN. No federal or Marine Corps endorsement is implied. If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.	Michael O’Donnell, M.D., FACS Professor of Urology Holden Cancer Center, University of Iowa Hospital Dr. O’Donnell received his M.D. degree from Duke University. He was a resident in urology, clinical and research fellow, instructor, and assistant professor in surgery at Harvard and a biomedical research fellow at the Whitehead Institute and Beth Israel Deaconess Medical Center in Boston. He is currently Director of Urologic Oncology at the University of Iowa. The author of over 50 peer-reviewed manuscripts, 10 book chapters, and multiple reviews and abstracts, Dr. O’Donnell also serves on the editorial board of the Journal of Urology and CURE. He leads several national clinical trials using immune therapy to treat bladder cancer and holds patents in the genetic manipulation of BCG bacteria. Click here for more information.	Search Our Site

Home | Financials | Privacy Policy | Site Map | Contact Us

4915 St. Elmo Avenue, Suite 202, Bethesda, Maryland 20814
PHONE: (301) 215-9099 TOLLFREE: 888-901-BCAN EMAIL: info@bcan.org

Find BCAN on Facebook

Follow BCAN on Twitter

Hope After Recurrence